Types of Cancer We Treat

Breast Cancer

We build your team of breast cancer experts based on your needs, providing personalized, compassionate care.

First, we identify the specific type of breast cancer using microscopic analysis, genetic testing, and imaging. Then, we create an individualized treatment plan for you. We provide the most advanced treatments, such as breast-conserving surgery and targeted drugs, and our researchers evaluate promising new treatments for breast cancer in clinical trials.

We offer comprehensive support services, including fertility preservation counseling, psychological support, and integrative therapies.

We counsel women who are at high risk for developing breast cancer, and our experts frequently provide second opinions.

Find a Doctor & Schedule
Diagnosis
Surgery
Breast Reconstruction
Chemotherapy & Other Systemic Therapies
Radiation Therapy

Related News

Advances in Cancer Detection & Screening Guidelines
Read Story
Heart Attacks May Encourage Cancer Growth
Read Story
Timely Cancer Care During COVID-19 Makes All the Difference
Read Story
Mammogram Screening for Women with the BRCA Gene Mutation
Read Story
Radiologists & AI Together Better at Detecting Breast Cancer
Read Story
A Triumph Over the Most Aggressive Form of Breast Cancer
Read Story
A Breast Cancer Diagnosis Turns a Patient into an Advocate
Read Story
Breast Self-Exam Remains Useful Tool for Cancer Detection
Read Story
A Conversation with Surgeon Dr. Freya R. Schnabel
Read Story
New Drug Slows Progression of Advanced Breast Cancer
Read Story
Woman Learns of Misdiagnosis After Double Mastectomy
Read Story
NYU Winthrop Recognized for Hidden Scar Breast Surgery
Read Story

Clinical Trials and Research Studies

Phase 5

A Multicenter Phase I/II Trial of Anastrozole Palbociclib Trastuzumab and Pertuzumab in HR-positive Her2-positive Metastatic Breast Cancer (ASPIRE)

Learn More

Phase 3

RT CHARM: PHASE III RANDOMIZED TRIAL OF HYPOFRACTIONATED POST MASTECTOMY RADIATION WITH BREAST RECONSTRUCTION (ALLIANCE A221505)

Learn More

Phase 3

Phase III Study of sacituzumab govitecan (IMMU-132) Versus Treatment of Physicians Choice (TPC) in Hormonal Receptor Positive (HR+) HER2 Negative Metastatic Breast Cancer (MBC) who have failed at least one prior line of chemotherapy (IMMU-132-09)

Learn More

Phase 2

Radiation Dermatitis: A phase 1 randomized double blinded placebo controlled study of the safety and efficacy of a caffeine-based antifibrosis cream in patients with breast cancer undergoing radiation therapy (ReDCoAT Study)

Learn More
View All Related Clinical Trials (23)